1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
AngioSoma, Inc.

AngioSoma, Inc.

SOAN
AngioSoma, Inc.US flagOther OTC
0.07
USD
+0.01
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Alex K. Blankenship
Sector
Healthcare
Industry
Biotechnology
Address
2500 Wilcrest Drive Houston TX United States of America
IPO Date
Jun 7, 2016
CIK
0001502152
Website
angiosoma.com
Similar Companies
MEDINET Co., Ltd. (2370.T)
Mycenax Biotech Inc. (4726.TWO)
Harpoon Therapeutics, Inc. (HARP)
IGC Pharma, Inc. (IGC)
Acer Therapeutics Inc. (ACER)
Regnum Corp. (RGMP)
Business
GlobeStar Therapeutics Corporation, formerly known as AngioSoma, Inc., operates as a clinical-stage pharmaceutical enterprise based in New York, New York. Founded in 2016, the company is dedicated to advancing patented drug formulations for treating neurodegenerative conditions, notably multiple sclerosis. Additionally, it delivers a selection of premium wellness and dietary supplements to the market.

Company News

APIChat

  • defenseworld.net

    Head-To-Head Review: AngioSoma (OTCMKTS:SOAN) & Calliditas Therapeutics AB (publ) (NASDAQ:CALT)